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RAPID COMMUNICATIONS 
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Hypersensitivity in Mice 
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Photocarcinogenesis and Photoimmunology Group, LEI-Basic Research Program, NCI-Frederick Cancer Research Facility, 
Frederick, Maryland, U.S.A. 
Ultraviolet, 280-320 nm (UVB), irradiation of the 
shaved dorsal skin of mice results in suppression of the 
development of contact hypersensitivity (CHS) to anti-
gens applied subsequently to a distant nonirradiated 
skin site. Serum from BALB/cAnNCr mice exposed to a 
single dose of UVB radiation (8.6 x 104 J/m2 ) was eval-
uated for its ability to induce suppression of CHS to 2-
chloro-1,3,5-trinitrobenzene (TNCB), a contact aller-
gen, after transfer to normal recipients. Serum from 
UVB-irradiated donors was capable of inducing immu-
nosuppression only when collected and transferred 
within a restricted time period, i.e., approximately 2-6 
h post irradiation, and at least 400 f.Ll of serum per 
recipient was required. Serum from UVB-irradiated do-
nors was sufficient to induce splenic suppressor cells in 
recipient mice. 
UVB irradiation of the dorsal skin of mice has been shown 
to result in systemic suppression of the immune response both 
to contact allergens and to tumor challenge with UV radiation-
induced tumors [1-4]. Work by several investigators has shown 
that the UVB-induced immunosuppression is associated with 
defective function ing of antigen-presenting cells (APC) in t he 
spleen, which may result in the appearance of antigen-specific 
suppressor T cells [5-9], but it · is unclear how the necessary 
signals from the irradiated site are transmitted internally to 
cause the APC dysfunction. One hypothesis is that soluble 
mediators are released at t he irradiated skin site by damaged 
or stimulated cells. The mediators presumably circulate via the 
lymph or blood to internal organs where they interact either 
directly with APC or indirectly by initiating a series of events 
culminating in t he APC defect. This study provides evidence 
that a factor(s) capable of inducing systemic immunosuppres-
sion can be found in the serum of UVB-irradiated mice. The 
appearance of th e factor(s) occurs very early post irradiation 
and is transient, but in conjunction with an appropriate anti-
gen, TNCB, it is sufficient to assist in t he induction of sup -
pressor cells in the spleens of recipient mice. 
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Abbreviations: 
APC: antigen-presenting cell (s) 
CHS: Contact hypersensitivity 
HBSS: Hanks' balanced salt solution 
TNCB: 2-chloro-1,3,5-trinitrobenzene 
UVB: ultraviolet radiation (280- 320 nm) 
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MATERIALS AND METHODS 
Specific-pathogen-free BALB/ cAnNCr female mice, 10- 12 weeks 
old, were supplied by the Animal Production Area of the NCI-Frederick 
Cancer Research Facility. The mice were fed NIH-31 open formula diet 
and chlorinated water (15 ppm) ad libitum. 
A single 3-h exposure (8.6 X 10' J / m2) of UVB radiation was 
adm inistered using a bank of 6 FS40 sunlamps (Westinghouse, Bloom-
field, New Jersey), which delivered an average dose rate of 8.0 J / m2/ s 
to the shaved dorsal surface of the mice [10]. During irradiation, the 
m1ce were confined in Plexiglas dividers, and the ears of those to be 
tested for CHS were covered with black electrical tape to protect the 
ears from radiation. AU sham-treated mice were shaved and treated 
identically except that they were not exposed to the UVB radiation. 
Blood from sham-treated or UVB-irradiated mice was obtained by 
retroorbital exsanguination after induction of anesthesia with meta-
fane. The blood was allowed to clot at room temperature for 30 min, 
then centrifuged at 1000 g for 20 min at room temperature. The serum 
fraction from appropriate groups was pooled and transferred immedi-
ately as undiluted serum to normal recipient mice via tail vein injec-
tions. 
On day 5 following treatment or serum transfer, the abdomens of a ll 
mice to be tested were razor shaved. Half of the mice in each group 
were then sensitized by painting the shaved area with 100 p.l of 3% 
TNCB in acetone. The other half were painted only with vehicle 
(acetone). Seven days later, a challenge dose of 5 pi of 1% TNCB in 
acetone was applied to both surfaces of each ear on all mice. Ear 
thickness was measured prior to challenge and 24 h later with an 
engineer's micrometer (Swiss Precision Instruments, Inc., Los Angeles, 
California). This protocol has been shown to yield maximum response 
to TNCB in this laboratory (4] . CHS to TNCB was determined as the 
amount of ear swelling of sensitized mice minus the amount of ear 
swelling of nonsensitized mice from the same group and was designated 
6. ear swelling. Each group consisted of 5 nonsensitized and 5 sensitized 
mice. All experiments were repeated at least 4 times and the data 
presented are consistent with each result. 
Spleens from appropriate groups were aseptically removed, teased in 
ice-cold Hanks' balanced salt solution (HBSS), pH 7.4 , pooled, and 
passed through nylon mesh to yield single-cell suspensions. After 4 
washes in cold HBSS, 1 X 108 viable nucleated spleen cells were 
transferred into normal mice via tail vein injection. Recipients were 
immediately sensitized to TNCB and challenged 7 days later, as de-
scribed above. 
The significance of the difference between means was determined 
by using Student's t-test. 
RESULTS 
On day 0, a large group of mice was UVB irradiated for 3 h. 
At various times from 20 min to 24 h post irradiation, 20 mice 
were exsanguinated and the sera were pooled and transferred 
to normal recipients. Ten UVB-irradiated mice were retained 
for CHS testing as positive UVB controls. Normal mouse sera 
were collected 3 h after sham treatment, pooled, and transferred 
to normal recipients. Ten sham-treated mice were retained for 
CHS testing as negative controls. The control mice and serum 
recipients were sensitized to TNCB on day 5 and challenged 
on day 12. Immediately after UVB irradiation (,;;; 20 min) the 
serum of irradiated mice contained a factor(s) that enhanced 
the CHS reaction to TNCB in normal recipients (Fig 1). 
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FIG 1. Kinetics of serum activity. At various times after UVB irra-
diation, 750 ILl of pooled serum from sham-treated or UVB-irradiated 
donors was transferred to normal recipient mice. Serum recipients and 
donor controls were sensitized to TNCB 5 days later and challenged 
12 days later. UVB-irradiated donors exhibited 66.1% suppression of 
CHS compared to sham-treated donors. Number in. parentheses is the 
% suppression of CHS in recipients of UVB serum (0-0) compared to 
the recipients of sham-treated serum (0) . 
However, at 3 h post irradiation, the serum suppressed CHS in 
normal recipients. At 6 h, some (18.9%) suppressive capability 
remained, but by 9 h, the effect of the serum from UVB-
irradiated donors was indistinguishable from that of normal 
mouse serum. Suppression of CHS was seen in serum recipients 
on ly when 400 J.Ll or more of whole serum from irradiated 
donors was transferred (data not shown) . 
For spleen cell transfer experiments, pooled serum collected 
3 h after sham treatment or UVB irradiation was t ransferred 
into normal recipients. Following routine CHS testing of the 
serum recipients, spleen cells from sensitized serum recipients 
were transferred to a new group of normal mice. These spleen 
cell recipients w~re immediately sensitized to TNCB and then 
challenged 7 days later. If the factor(s) in serum from UVB-
irradiated mice acts via a mechanism the same as or similar to 
that seen in directly irradiated animals (i.e., dysfunction of 
APC and subsequent appearance of suppressor T cells in the 
spleen), then the transfer of spleen cells from serum recipients 
should also transfer suppression of CHS. The finding that 
normal mice that received spleen cells from the UVB serum 
recipients also exhibited suppression of CHS (55.2%) (Fig 2) 
indicates that serum from UVB-irradiated mice was involved 
in the induction of suppressor cells. The responses of mice that 
received spleen cells from the group injected with serum from 
sham-treated mice were not different from the responses of 
normal mice, indicating that normal serum did not contain the 
factor(s) necessary to assist in the induction of such suppressor 
cells. 
DISCUSSION 
One of the major questions raised by UVB-induced suppres-
sion of CHS is how the events that occur at the irradiated site 
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result in the abnormal response to an antigen applied at a 
distant nonirradiated site. The findings of this study show that 
serum from UVB-irradiated mice is capable of inducing im-
munosuppression of CHS in normal recipients. In addition, 
this suppression is shown to be associated with the generation 
of suppressor cells found in the spleens of serum recipients. 
The release of soluble immunomodulators after UV irradia-
tion of skin has been shown to occur. Prostaglandins E and F 
can be found in increased levels in the epidermis at the irradi-
ated site [11], and the release of epidermal cell thymocyte-
activating factor (a substance similar to interleukin 1), which 
is produced by keratinocytes in the skin, has been shown to be 
affected by UV irradiation [12-14). Also, studies on the UV 
action spectrum for immunosuppression of CHS suggest that 
the photoreceptor for this response may be urocanic acid, a 
soluble compound located in the superficial layers of the epi-
dermis [15] . Although these and other immunomodulators have 
been associated with the erythema caused by UV radiation [11) 
or with alteration of immune responses [12-14,16], no associ-
ation of these or other agents with the induction of systemic 
immunosuppression following UV irradiation has been shown. 
Furthermore, it is not known whether the factor(s) found in 
the serum of UVB-irradiated mice in the present study is a new 
immunomodulator or a known immunomodulator functioning 
in a heretofore undescribed capacity. 
The involvement of the serum factor(s) in the primary events 
leading to the induction of immunosuppression of CHS is 
suggested by several lines of evidence. First, the rapid and 
transient nature of the appearance of the factor(s) in serum 
(within approximately 2- 6 h after UVB irradiation) indicates 
that the factor(s) is most likely an acute response to the 
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F IG 2. Induction of suppressor spleen cells by UVB serum. Viable 
nucleated spleen cells (1 X 108) were transferred to normal mice from 
donors that had previously received 750 1'1 of serum and been tested 
for CHS. Recipients were sensitized to TNCB immediately and chal-
lenged 7 days later. Normal = control group receiving no cells. NMS-
SC = group receiving cells from recipients of sham-treated serum. 
UVBS-SC = group receiving cells from recipients of UVB-irradiated 
serum. Number in parentheses is the % suppression of CHS in UVBS-
SC recipients compared to NMS-SC recipients. 
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irradiation. Second, although the concentration of the factor(s) 
appears dilute, as evidenced by the fact that at least 400 tLl of 
whole serum is necessary for transfer, even at the peak of 
activity, it is sufficient to induce immunosuppression, allowing 
for subsequent events such as the appearance of suppressor 
cells or defective APC to amplify the effects of the factor(s). 
Third, the appearance after serum transfer of suppressor cells 
in the spleens of serum recipients indicates that the factor(s) 
is involved prior to the appearance of suppressor cells. 
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